SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001703057-23-000030
Filing Date
2023-09-14
Accepted
2023-09-14 16:38:44
Documents
1
Period of Report
2023-09-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1694723915.html 4  
1 FORM 4 wk-form4_1694723915.xml 4 6032
  Complete submission text file 0001703057-23-000030.txt   7387
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Issuer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ABCELLERA BIOLOGICS INC. 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address
Lecault Veronique (Reporting) CIK: 0001834418 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39781 | Film No.: 231255580